.png){kind=small}
BOTH ARE FDA-APPROVED
Unlike most comparisons on this site, this one is between two approved medicines. Both are testosterone esters with FDA labels, and both are Schedule III controlled substances.
PHYSICIAN-DIRECTED SERMORELIN CARE IN FLORIDA
Testosterone Cypionate vs. Enanthate: What the FDA Labels Actually Say
Nearly every comparison of these two opens with half-life and treats it as the deciding factor. We read both FDA labels side by side. One of them states a half-life and the other does not state one at all — and the difference that could actually change which one is safe for you is not the half-life. It is the oil.
Timothy Mackey, D.O., Medical Director
Florida License OS9185 · Updated September 2026
A consultation does not guarantee a prescription. Eligible Florida patients may be seen by telemedicine when clinically appropriate.
Timothy Mackey, D.O.Medical Director · Physician-led evaluation and monitoring
PHYSICIANIndividual evaluation
FLORIDALicense OS9185
★★★★★4.9 Google rating
A+BBB rating
MONITORINGOngoing follow-up
Three things to know before choosing between them
DIFFERENT CARRIER OILS
Cypionate is suspended in cottonseed oil. Enanthate is suspended in sesame oil. For a patient with a sesame allergy that is not a footnote, and it is the one difference with a clear clinical consequence.
SAME LABELED INTERVAL
Both labels give the same dosing interval guidance of two to four weeks. The claim that one lets you inject less often than the other is not something either label supports.
The half-life comparison everyone leads with
Search this question and you will be told, confidently and almost everywhere, that cypionate has a half-life of about eight days and enanthate about four and a half, and that this is why cypionate is the better choice. The figures are usually presented as though both came from the products’ labels.
Only one of them does.
The Depo-Testosterone label states it directly: “The half-life of testosterone cypionate when injected intramuscularly is approximately eight days.” That is a label fact and you can rely on it.
The Delatestryl label does not state a half-life at all. The commonly quoted four-to-five-day figure for enanthate comes from the pharmacology literature, not from that label — which is a perfectly legitimate source, but it is not the same kind of claim, and presenting the two numbers as an apples-to-apples label comparison is not accurate.
There is a second problem with leaning on the comparison. The published half-life figures for enanthate vary between sources, and the difference between the two esters is one carbon atom in the side chain. In practice the two behave far more alike than the charts imply, which is why the labels give them the same dosing interval.
None of this means half-life is irrelevant. It means it is a thinner basis for choosing than the internet suggests, and that anyone presenting it as the decisive factor has not read both labels.
Cottonseed or sesame: the difference that can actually matter
Testosterone esters are oil-soluble, so they are dissolved in a carrier oil before injection. The two products do not use the same oil, and this is the difference most comparisons mention in passing, if at all.
Cypionate: cottonseed oil
The Depo-Testosterone label lists cottonseed oil as the vehicle, along with benzyl benzoate and benzyl alcohol as a preservative. The label carries a warning that benzyl alcohol has been associated with serious adverse events in paediatric patients.
Enanthate: sesame oil
The Delatestryl label lists sesame oil with chlorobutanol as a preservative.
Why this is the one to actually pay attention to: sesame is a recognised food allergen, and a meaningful number of people are allergic to it. A patient with a sesame allergy being handed enanthate is a real clinical problem, not a theoretical one. The same logic applies in reverse for anyone with a known cottonseed or benzyl alcohol sensitivity.
This belongs in the conversation before a prescription is written. It is a question worth raising yourself if nobody asks you — and it is a far better reason to prefer one ester over the other than any half-life chart.
What each label is actually approved for
They overlap on the indication that brings most men to this page, and then they diverge.
Both are approved for testosterone replacement
The Depo-Testosterone label states it is “indicated for replacement therapy in the male in conditions associated with symptoms of deficiency or absence of endogenous testosterone,” listing primary hypogonadism and hypogonadotropic hypogonadism, congenital or acquired. The enanthate label carries the same two conditions.
Enanthate’s label covers more ground
Beyond replacement therapy, the Delatestryl label adds delayed puberty and, secondarily, metastatic mammary cancer — specifically in women one to five years postmenopausal with advancing inoperable metastatic disease.
That does not make enanthate a better choice for testosterone replacement in men. It means the two products were approved at different times for different sets of uses, and it is the reason you will occasionally see enanthate described as having “broader” indications. For the hypogonadism indication that applies to most patients, the two labels say the same thing.
Both are Schedule III controlled substances
Both labels state it plainly. Testosterone in any ester is a controlled substance in the United States, which is why it requires a prescription from a licensed prescriber after an evaluation, and why material offering to supply it without one should be treated with suspicion.
How often do the labels say to inject?
This is where the half-life argument is supposed to pay off — the longer-acting ester should mean fewer injections. The labels do not draw that distinction.
Both labels give the same interval guidance: two to four weeks. The Delatestryl label goes further and states that injections more frequently than every two weeks are rarely indicated.
It is worth knowing that a great deal of contemporary testosterone practice uses more frequent schedules than the labels describe, on the reasoning that smaller, more frequent doses produce steadier levels. That is a real clinical debate with real arguments on both sides. It is also, relative to the label language above, off-label — and a patient is entitled to know that the schedule they are given may not be the schedule the label describes, whichever ester is in the syringe.
We are deliberately not publishing an injection schedule here. What to inject, how much and how often is a prescribing decision that depends on your labs, your diagnosis and your response — not on an article.
Which one should you be on?
For most men the honest answer is that it will not be the thing that decides how treatment goes. Both are testosterone. Both are approved for the same core indication. Dose, monitoring, injection technique and whether the underlying diagnosis was correct in the first place matter far more than which ester is in the vial.
The factors that genuinely do point one way or the other:
- A sesame allergy points away from enanthate, because sesame oil is its vehicle.
- A cottonseed or benzyl alcohol sensitivity points away from cypionate, for the same reason in reverse.
- Supply and cost. Availability shifts, and the two are not always stocked or priced alike.
- Which product your prescriber and pharmacy actually work with, which is a more practical consideration than most articles admit.
What should not decide it is a half-life figure quoted from a website, because as the section above shows, one of the two numbers being compared is not on the label being cited.
If the question behind the question is whether you need testosterone therapy at all, that is the more important conversation — and it starts with appropriate testing, not with choosing an ester. Our testosterone replacement page covers how candidacy is actually assessed.
A four-step physician-guided process
Consultation
Review symptoms, goals, medical history, medications, and prior treatment.
Evaluation
Complete a focused exam, records review, and labs when clinically appropriate.
Shared decision
Compare evidence, regulatory status, alternatives, uncertainty, cost, and risk.
Follow-up
If treatment is appropriate, monitor response, side effects, and ongoing need.
In-person and telemedicine care
NovaGenix serves patients at 609 N. Hepburn Ave., Suite 106, Jupiter, Florida, with telemedicine available to eligible patients throughout Florida.
Clear next steps after evaluation
Cost and availability depend on the medically appropriate option, pharmacy or product, monitoring, and insurance status. The team explains expected costs before treatment begins.
Common questions about cypionate and enanthate
Is cypionate or enanthate better for TRT?
Neither label supports calling one better for testosterone replacement. Both are FDA-approved for the same core indication, both are Schedule III controlled substances, and both labels give the same dosing interval guidance of two to four weeks. The factors that genuinely differentiate them are the carrier oil, availability and cost, not effectiveness.
What is the difference in carrier oil?
Testosterone cypionate is suspended in cottonseed oil, with benzyl benzoate and benzyl alcohol as a preservative. Testosterone enanthate is suspended in sesame oil with chlorobutanol as a preservative. Sesame is a recognised food allergen, so a patient with a sesame allergy should raise it before enanthate is prescribed, and anyone with a known cottonseed or benzyl alcohol sensitivity should raise it before cypionate is prescribed.
Does cypionate really have a longer half-life?
The Depo-Testosterone label states that the half-life of testosterone cypionate when injected intramuscularly is approximately eight days. The Delatestryl label does not state a half-life for enanthate at all, so the commonly quoted four-to-five-day figure comes from the pharmacology literature rather than from that label. The two numbers are often presented as an equivalent label-to-label comparison, and they are not.
Can you switch from one to the other?
Switching between testosterone esters is a prescribing decision and is done in practice for reasons including supply, cost and tolerance of the carrier oil. It is not something to do independently of the prescriber who is monitoring your labs, because dose and interval may need to be reconsidered at the same time.
Are they controlled substances?
Yes. Both the Depo-Testosterone and Delatestryl labels state that the product is a Schedule III controlled substance. Testosterone in any ester requires a prescription from a licensed prescriber following an evaluation, and any source offering to supply it without one should be treated with suspicion.
Is enanthate approved for more conditions than cypionate?
The enanthate label covers delayed puberty and, secondarily, metastatic mammary cancer in women one to five years postmenopausal, in addition to testosterone replacement. The cypionate label covers replacement therapy in the male. For the hypogonadism indication that applies to most patients seeking testosterone therapy, the two labels say the same thing, and the broader list does not make enanthate a better choice for replacement.
Talk to a physician about which ester fits you
Discuss your goals, medical history, evidence-based options, and whether this therapy—or a different approach—may be appropriate.
